Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research highlights benefits of milk prebiotic for cats and dogs
Cats and dogs fed food containing milk oligosaccahrides in the study showed no adverse health effects.

Scientists assess the effects of milk oligosaccaharides on gut health. 

Researchers at the University of Illinois have found that milk oligosaccaharides could be beneficial to cats and dogs when added to their diets.

Milk oligosaccahraides are complex carbohydrate supplements that are naturally present in mammalian milk.

In recent years, human milk oligosaccahraides have attracted much attention owing to their role in boosting beneficial gut microbes in babies. Now, new research suggests they could benefit cats and dogs, too.

In the first of three studies, researchers identified the predominant oligosaccharide structures in canine and feline milk. Their findings are published in PloS ONE.

In canine milk, the team identified three structures that make up more than 90 per of total oligosaccharides. Feline milk was more complex and balanced, with around 15 compounds making up 90 per cent of total oligosaccharides.

"Our study was the first robust characterization of dog and cat milk oligosaccharides,” commented Professor Kelly Swanson, lead author of the study. “Our data not only provide a better understanding of how milk meets the nutritional needs of newborn kittens and puppies, but also how it helps promote gut immunity and establish a healthy gut microbial community early in life.”

Next, researchers tested the safety, palatability and digestibility of an animal milk oliosaccahraide-like product called GNU100. GNU100 was launched by Swiss biotech firm Gnubiotics Sciences in 2019 but had not been tested on animals.

After testing confirmed the product was not toxic, the team mixed GNU100 at one per cent with a fat source and coated commercial dry diets for cats or dogs. Fat-coated diets without GNU100 were also offered as a control. 

They found that when the animals had the option to choose between the control and the one per cent bowls, they went crazy for the GNU100. 

Prof. Swanson said: “In the cats, it was a huge preference. They ate nearly 18 times more food with GNU100 than the control food. We had just been hoping they wouldn’t reject it.
You know, cats can be pretty finicky. When we got the data back it was like, wow, they really love that stuff! And the dogs did, too.” 

Finally, Swanson and his team included GNU100 in experimental diets at 0 per cent, 0.5 per cent, 1 per cent, and 1.5 per cent and fed them to healthy adult dogs and cats for six months. Stool quality, blood metabolites, and nutrient digestibility were measured throughout the experiment, as were changes in gut metabolites and the gut microbial community. 

The team noted that cats did well with GNU100, with no adverse health effects. Researchers also saw shifts in the gut microbiome toward more beneficial species and their metabolite profiles.

“Theoretically, these products should stabilize and feed good bacteria in the gut as well as limit the growth of potentially undesirable bacteria. So if an animal is undergoing treatment for something with antibiotics or is in a high stress situation, having that product in the diet might keep the gut from destabilizing,” said Prof. Swanson.

“Another target group for these products might be young animals as a way to maintain beneficial bacteria in the gut as they wean off their mothers. We’d need to do more testing to see if the product holds up in those target groups, but at least we know now that it is safe and well tolerated.”

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'